Selected research
Industry Research
Phytopeptides Industry Research Report 2026
Market perspective
The global Phytopeptides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Phytopeptides is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Phytopeptides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Phytopeptides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Phytopeptides include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Phytopeptides market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Phytopeptides.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Phytopeptides Market by Company
Hubei Reborn Biotech
Phytocare
Ingredients To Die For
Fujian Dazhong Health Biotechnology
Theobroma Grandiflorum Seed Butter (and) Glycerin
Annzyme
Dezhou Lanli Biotechnology
Zhongshi Duqing (shandong) Biotech
Tallyho
Biosynth
AmbioPharm
Aurobindo Pharma
Yasin Gelatin
Bachem
Creative Peptides
Shanghai Soho-Yiming Pharmaceuticals
Phytopeptides Segment by Type
Soy Peptides
Rice Peptides
Corn Peptides
Others
Phytopeptides Segment by Application
Health Food
Cosmetics
Others
Phytopeptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phytopeptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phytopeptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phytopeptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Phytopeptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Phytopeptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Phytopeptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Soy Peptides
- Rice Peptides
- Corn Peptides
- Others
Applications
- Health Food
- Cosmetics
- Others
Companies covered
- Hubei Reborn Biotech
- Phytocare
- Ingredients To Die For
- Fujian Dazhong Health Biotechnology
- Theobroma Grandiflorum Seed Butter (and) Glycerin
- Annzyme
- Dezhou Lanli Biotechnology
- Zhongshi Duqing (shandong) Biotech
- Tallyho
- Biosynth
- AmbioPharm
- Aurobindo Pharma
- Yasin Gelatin
- Bachem
- Creative Peptides
- Shanghai Soho-Yiming Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Phytopeptides by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Soy Peptides
- 2.2.3 Rice Peptides
- 2.2.4 Corn Peptides
- 2.2.5 Others
- 2.3 Phytopeptides by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Health Food
- 2.3.3 Cosmetics
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Phytopeptides Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Phytopeptides Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Phytopeptides Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Phytopeptides Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Phytopeptides Production by Manufacturers (2021-2026)
- 3.2 Global Phytopeptides Production Value by Manufacturers (2021-2026)
- 3.3 Global Phytopeptides Average Price by Manufacturers (2021-2026)
- 3.4 Global Phytopeptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Phytopeptides Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Phytopeptides Manufacturers, Product Type & Application
- 3.7 Global Phytopeptides Manufacturers Established Date
- 3.8 Global Phytopeptides Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hubei Reborn Biotech
- 4.1.1 Hubei Reborn Biotech Phytopeptides Company Information
- 4.1.2 Hubei Reborn Biotech Phytopeptides Business Overview
- 4.1.3 Hubei Reborn Biotech Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Hubei Reborn Biotech Product Portfolio
- 4.1.5 Hubei Reborn Biotech Recent Developments
- 4.2 Phytocare
- 4.2.1 Phytocare Phytopeptides Company Information
- 4.2.2 Phytocare Phytopeptides Business Overview
- 4.2.3 Phytocare Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Phytocare Product Portfolio
- 4.2.5 Phytocare Recent Developments
- 4.3 Ingredients To Die For
- 4.3.1 Ingredients To Die For Phytopeptides Company Information
- 4.3.2 Ingredients To Die For Phytopeptides Business Overview
- 4.3.3 Ingredients To Die For Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Ingredients To Die For Product Portfolio
- 4.3.5 Ingredients To Die For Recent Developments
- 4.4 Fujian Dazhong Health Biotechnology
- 4.4.1 Fujian Dazhong Health Biotechnology Phytopeptides Company Information
- 4.4.2 Fujian Dazhong Health Biotechnology Phytopeptides Business Overview
- 4.4.3 Fujian Dazhong Health Biotechnology Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Fujian Dazhong Health Biotechnology Product Portfolio
- 4.4.5 Fujian Dazhong Health Biotechnology Recent Developments
- 4.5 Theobroma Grandiflorum Seed Butter (and) Glycerin
- 4.5.1 Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Company Information
- 4.5.2 Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Business Overview
- 4.5.3 Theobroma Grandiflorum Seed Butter (and) Glycerin Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Theobroma Grandiflorum Seed Butter (and) Glycerin Product Portfolio
- 4.5.5 Theobroma Grandiflorum Seed Butter (and) Glycerin Recent Developments
- 4.6 Annzyme
- 4.6.1 Annzyme Phytopeptides Company Information
- 4.6.2 Annzyme Phytopeptides Business Overview
- 4.6.3 Annzyme Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Annzyme Product Portfolio
- 4.6.5 Annzyme Recent Developments
- 4.7 Dezhou Lanli Biotechnology
- 4.7.1 Dezhou Lanli Biotechnology Phytopeptides Company Information
- 4.7.2 Dezhou Lanli Biotechnology Phytopeptides Business Overview
- 4.7.3 Dezhou Lanli Biotechnology Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Dezhou Lanli Biotechnology Product Portfolio
- 4.7.5 Dezhou Lanli Biotechnology Recent Developments
- 4.8 Zhongshi Duqing (shandong) Biotech
- 4.8.1 Zhongshi Duqing (shandong) Biotech Phytopeptides Company Information
- 4.8.2 Zhongshi Duqing (shandong) Biotech Phytopeptides Business Overview
- 4.8.3 Zhongshi Duqing (shandong) Biotech Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Zhongshi Duqing (shandong) Biotech Product Portfolio
- 4.8.5 Zhongshi Duqing (shandong) Biotech Recent Developments
- 4.9 Tallyho
- 4.9.1 Tallyho Phytopeptides Company Information
- 4.9.2 Tallyho Phytopeptides Business Overview
- 4.9.3 Tallyho Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Tallyho Product Portfolio
- 4.9.5 Tallyho Recent Developments
- 4.10 Biosynth
- 4.10.1 Biosynth Phytopeptides Company Information
- 4.10.2 Biosynth Phytopeptides Business Overview
- 4.10.3 Biosynth Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Biosynth Product Portfolio
- 4.10.5 Biosynth Recent Developments
- 4.11 AmbioPharm
- 4.11.1 AmbioPharm Phytopeptides Company Information
- 4.11.2 AmbioPharm Phytopeptides Business Overview
- 4.11.3 AmbioPharm Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 AmbioPharm Product Portfolio
- 4.11.5 AmbioPharm Recent Developments
- 4.12 Aurobindo Pharma
- 4.12.1 Aurobindo Pharma Phytopeptides Company Information
- 4.12.2 Aurobindo Pharma Phytopeptides Business Overview
- 4.12.3 Aurobindo Pharma Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Pharma Product Portfolio
- 4.12.5 Aurobindo Pharma Recent Developments
- 4.13 Yasin Gelatin
- 4.13.1 Yasin Gelatin Phytopeptides Company Information
- 4.13.2 Yasin Gelatin Phytopeptides Business Overview
- 4.13.3 Yasin Gelatin Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Yasin Gelatin Product Portfolio
- 4.13.5 Yasin Gelatin Recent Developments
- 4.14 Bachem
- 4.14.1 Bachem Phytopeptides Company Information
- 4.14.2 Bachem Phytopeptides Business Overview
- 4.14.3 Bachem Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Bachem Product Portfolio
- 4.14.5 Bachem Recent Developments
- 4.15 Creative Peptides
- 4.15.1 Creative Peptides Phytopeptides Company Information
- 4.15.2 Creative Peptides Phytopeptides Business Overview
- 4.15.3 Creative Peptides Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Creative Peptides Product Portfolio
- 4.15.5 Creative Peptides Recent Developments
- 4.16 Shanghai Soho-Yiming Pharmaceuticals
- 4.16.1 Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Company Information
- 4.16.2 Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Business Overview
- 4.16.3 Shanghai Soho-Yiming Pharmaceuticals Phytopeptides Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Shanghai Soho-Yiming Pharmaceuticals Product Portfolio
- 4.16.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
5 Global Phytopeptides Production by Region
- 5.1 Global Phytopeptides Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Phytopeptides Production by Region: 2021-2032
- 5.2.1 Global Phytopeptides Production by Region: 2021-2026
- 5.2.2 Global Phytopeptides Production Forecast by Region (2027-2032)
- 5.3 Global Phytopeptides Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Phytopeptides Production Value by Region: 2021-2032
- 5.4.1 Global Phytopeptides Production Value by Region: 2021-2026
- 5.4.2 Global Phytopeptides Production Value Forecast by Region (2027-2032)
- 5.5 Global Phytopeptides Market Price Analysis by Region (2021-2026)
- 5.6 Global Phytopeptides Production and Value, YOY Growth
- 5.6.1 North America Phytopeptides Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Phytopeptides Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Phytopeptides Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Phytopeptides Production Value Estimates and Forecasts (2021-2032)
6 Global Phytopeptides Consumption by Region
- 6.1 Global Phytopeptides Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Phytopeptides Consumption by Region (2021-2032)
- 6.2.1 Global Phytopeptides Consumption by Region: 2021-2026
- 6.2.2 Global Phytopeptides Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Phytopeptides Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Phytopeptides Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Phytopeptides Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Phytopeptides Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Phytopeptides Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Phytopeptides Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Phytopeptides Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Phytopeptides Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Phytopeptides Production by Type (2021-2032)
- 7.1.1 Global Phytopeptides Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Phytopeptides Production Market Share by Type (2021-2032)
- 7.2 Global Phytopeptides Production Value by Type (2021-2032)
- 7.2.1 Global Phytopeptides Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Phytopeptides Production Value Market Share by Type (2021-2032)
- 7.3 Global Phytopeptides Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Phytopeptides Production by Application (2021-2032)
- 8.1.1 Global Phytopeptides Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Phytopeptides Production Market Share by Application (2021-2032)
- 8.2 Global Phytopeptides Production Value by Application (2021-2032)
- 8.2.1 Global Phytopeptides Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Phytopeptides Production Value Market Share by Application (2021-2032)
- 8.3 Global Phytopeptides Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Phytopeptides Value Chain Analysis
- 9.1.1 Phytopeptides Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Phytopeptides Production Mode & Process
- 9.2 Phytopeptides Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Phytopeptides Distributors
- 9.2.3 Phytopeptides Customers
10 Global Phytopeptides Analyzing Market Dynamics
- 10.1 Phytopeptides Industry Trends
- 10.2 Phytopeptides Industry Drivers
- 10.3 Phytopeptides Industry Opportunities and Challenges
- 10.4 Phytopeptides Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst